WUSTL
   

"All health care providers and office personnel are extremely caring and helpful. It makes a big difference when you have a serious disease."

 : 

Clinical research and basic science research are part of the focus of the Division of Gynecologic Oncology. As a member institution of the Gynecologic Oncology Group (GOG), a multi-institutional clinical research group funded by the National Cancer Institute, the division has more than forty treatment protocols available, including investigational drugs not offered outside of the GOG. There are also multiple protocols which are sponsored by pharmaceutical companies. The division has a full-time data manager who administers the running of these clinical trials. The division has contributed patients to the GOG since 1987 and to the Radiation Therapy Oncology Group (RTOG) for the past 20 years. Over 2400 patients have been placed on GOG protocols since 1987, with 532 patients placed on protocol in 2006. Approximately 15% of patients requiring treatment for a gynecologic cancer are placed on a GOG protocol, with a smaller percentage placed on RTOG protocols. In addition, the division is one of a limited number of centers designated to test Phase I (experimental) studies for the GOG.

Washington University has members appointed to a number of GOG committees including Endometrial, Cervix, Ovary, Tumor and Applied Sciences, Radiation, Cancer Prevention and Control, Executive, Phase I, Basic Science, Data Management, and Nursing.